Desogestrel, Gestodene VTE Data Updated In U.K. Labeling
Executive Summary
U.K. labeling for oral contraceptives containing desogestrel or gestodene will be updated to include more specific information on the relative risk of venous thromboembolism in "third generation" OCs, the Department of Health Medicines Commission announced April 8.